Copy Link Print Information

Epratuzumab

(別名: Antibody hLL 2; AMG-412)
カスタマーレビュー

Based on 1 Customer Validation

Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度: 99.53%
  • CAS 番号: 205923-57-5
  • 分子量:146.58 kDa
  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Epratuzumab
  • Experimental Validation Results for Epratuzumab
  • Experimental Validation Results for Epratuzumab
  • Epratuzumab Chemical Structure
    Epratuzumab 構造式
CAS 番号: 205923-57-5
容量
価格（税別）
在庫状況
数量
Amount: USD 0.00
Please select quantity
or
or

* アイテムを追加する前、数量をご選択ください

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Epratuzumab おすすめ製品:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
最寄りの代理店をお探しください Your local distributor: Hycultec GmbHHycultec
  • 生物活性
  • 化学情報
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress ログイン
Register
Sign in to MedChemExpress
新規会員登録

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Siglec-2/CD22 Protein, Human can bind Epratuzumab. The EC50 for this effect is 12.52 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Epratuzumab (anti-Siglec-2/CD22) (HY-P99289). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.

  • Epratuzumab Chemical Structure
    1/16
  • Epratuzumab
  • Immobilized Siglec-2/CD22 Protein, Human can bind Epratuzumab. The EC50 for this effect is 12.52 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Epratuzumab (anti-Siglec-2/CD22) (HY-P99289). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.